BIOAVAILABILITY AND PHARMACOKINETICS IN MAN OF ACIPIMOX, A NEW ANTI-LIPOLYTIC AND HYPOLIPEMIC AGENT

被引：43

作者：

MUSATTI, L

MAGGI, E

MORO, E

VALZELLI, G

TAMASSIA, V

机构：

来源：

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 1981年 / 9卷 / 05期

关键词：

D O I：

10.1177/030006058100900515

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

收藏

页码：381 / 386

页数：6

相关论文

共 7 条

[1] AMBROGI V, 1980, EUR J MED CHEM, V15, P157
[2] FRAGIACOMO C, 1980, 7 INT S DRUG AFF LIP, P240
[3] INHIBITION OF LIPOLYSIS BY NICOTINIC-ACID AND BY ACIPIMOX
FUCCELLA, LM
GOLDANIGA, G
LOVISOLO, P
MAGGI, E
MUSATTI, L
MANDELLI, V
SIRTORI, CR
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (06) : 790 - 795
[4] PHARMACOLOGICAL PROFILE OF A NEW ANTI-LIPOLYTIC AGENT - 5-METHYL-PYRAZINE-2-CARBOXYLIC ACID 4-OXIDE (ACIPIMOX) .1. MECHANISM OF ACTION
LOVISOLO, PP
BRIATICOVANGOSA, G
ORSINI, G
RONCHI, R
ANGELUCCI, R
VALZELLI, G
[J]. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1981, 13 (02): : 151 - 161
[5] PHARMACOLOGICAL PROFILE OF A NEW ANTI-LIPOLYTIC AGENT - 5-METHYL-PYRAZINE-2-CARBOXYLIC ACID 4-OXIDE (ACIPIMOX) .2. ANTI-LIPOLYTIC AND BLOOD LIPID LOWERING ACTIVITY
LOVISOLO, PP
BRIATICOVANGOSA, G
ORSINI, G
RONCHI, R
ANGELUCCI, R
[J]. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1981, 13 (02): : 163 - 174
[6] REDUCED TRIGLYCERIDEMIA AND INCREASED HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AFTER TREATMENT WITH ACIPIMOX, A NEW INHIBITOR OF LIPOLYSIS
SIRTORI, CR
GIANFRANCESCHI, G
SIRTORI, M
BERNINI, F
DESCOVICH, G
MONTAGUTI, U
FUCCELLA, LM
MUSATTI, L
[J]. ATHEROSCLEROSIS, 1981, 38 (3-4) : 267 - 271
[7] WAGNER JG, 1975, FUNDAMENTALS CLIN PH, P136